| scholarly article | Q13442814 |
| P50 | author | Thibaut Larcher | Q37373430 |
| P2093 | author name string | Jack-Yves Deschamps | |
| Elisabeth Le Rumeur | |||
| Blandine Lieubeau | |||
| Isabelle Testault | |||
| Laurence Dubreil | |||
| Gregory Jouvion | |||
| Caroline Le Guiner | |||
| Karl Rouger | |||
| Mireille Ledevin | |||
| Yan Chérel | |||
| Marine Theret | |||
| Bruno Delorme | |||
| Isabelle Leroux | |||
| Lydie Guigand | |||
| Marine Carlus | |||
| Marc Fiszman | |||
| Benoît Fornasari | |||
| Céline Zuber | |||
| Priscilla Orlando | |||
| Stéphane Deleau | |||
| P2860 | cites work | VCAM-1 expression on dystrophic muscle vessels has a critical role in the recruitment of human blood-derived CD133+ stem cells after intra-arterial transplantation | Q24294978 |
| Myogenic specification of side population cells in skeletal muscle | Q24672806 | ||
| Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
| Mesoangioblasts--vascular progenitors for extravascular mesodermal tissues | Q28208566 | ||
| Population frequencies of inherited neuromuscular diseases—A world survey | Q28266298 | ||
| Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs | Q28274324 | ||
| Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix | Q28296676 | ||
| X chromosome-linked muscular dystrophy (mdx) in the mouse | Q28589078 | ||
| Pax7 is required for the specification of myogenic satellite cells | Q28593927 | ||
| Cell Therapy of -Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts | Q29302095 | ||
| Membrane organization of the dystrophin-glycoprotein complex | Q29615149 | ||
| Dystrophin: the protein product of the Duchenne muscular dystrophy locus | Q29618077 | ||
| Hematopoietic potential of stem cells isolated from murine skeletal muscle | Q33179264 | ||
| Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation | Q33185127 | ||
| Enhancement of myogenic and muscle repair capacities of human adipose-derived stem cells with forced expression of MyoD. | Q33713683 | ||
| Long-term self-renewal of postnatal muscle-derived stem cells | Q33877074 | ||
| Neuromuscular disorders in childhood. Old dogmas, new concepts | Q34064132 | ||
| Long-term persistence and migration of myogenic cells injected into pre-irradiated muscles of mdx mice | Q34306103 | ||
| Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. | Q34437918 | ||
| MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle. | Q34578181 | ||
| Self-renewal and expansion of single transplanted muscle stem cells | Q34833140 | ||
| A multidisciplinary evaluation of the effectiveness of cyclosporine a in dystrophic mdx mice. | Q35083651 | ||
| Neural stem cells: an overview | Q35099569 | ||
| Syndecan-4-expressing muscle progenitor cells in the SP engraft as satellite cells during muscle regeneration. | Q35124906 | ||
| Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle | Q35835194 | ||
| Canine and feline models of human inherited muscle diseases | Q36031704 | ||
| Development of approaches to improve cell survival in myoblast transfer therapy | Q36290641 | ||
| Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source | Q36293384 | ||
| Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model | Q36322999 | ||
| Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration | Q36324366 | ||
| Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. | Q36325014 | ||
| Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential | Q73492378 | ||
| Prevention by anti-LFA-1 of acute myoblast death following transplantation | Q73648269 | ||
| Cryptic splicing involving the splice site mutation in the canine model of Duchenne muscular dystrophy | Q73739696 | ||
| Development of a snapback method of single-strand conformation polymorphism analysis for genotyping Golden Retrievers for the X-linked muscular dystrophy allele | Q77905660 | ||
| Characterization of dystrophic muscle in golden retriever muscular dystrophy dogs by nuclear magnetic resonance imaging | Q80404899 | ||
| Muscle satellite cell heterogeneity: in vitro and in vivo evidences for populations that fuse differently | Q80477349 | ||
| Differential myocardial infarct repair with muscle stem cells compared to myoblasts | Q81123128 | ||
| Gait analysis using accelerometry in dystrophin-deficient dogs | Q84622157 | ||
| Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing | Q36328609 | ||
| Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse | Q36403623 | ||
| Duchenne muscular dystrophy: focus on pharmaceutical and nutritional interventions. | Q36669820 | ||
| Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles | Q36879972 | ||
| Kinematics of gait in golden retriever muscular dystrophy. | Q37184680 | ||
| Cell based therapy for Duchenne muscular dystrophy | Q37581545 | ||
| Human skeletal muscle-derived stem cells retain stem cell properties after expansion in myosphere culture | Q39788454 | ||
| Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone | Q39955104 | ||
| Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells | Q40243228 | ||
| Flow cytometric characterization of myogenic cell populations obtained via the preplate technique: potential for rapid isolation of muscle-derived stem cells | Q40700269 | ||
| Human myoblast transplantation: preliminary results of 4 cases | Q40734292 | ||
| Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. | Q40818700 | ||
| Cell transplantation for myocardial repair: an experimental approach | Q41088806 | ||
| Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation | Q41673982 | ||
| Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse | Q41902045 | ||
| Multipotential mesoangioblast stem cell therapy in the mdx/utrn-/- mouse model for Duchenne muscular dystrophy | Q42512827 | ||
| Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice | Q43769886 | ||
| Muscular dystrophy in a litter of golden retriever dogs | Q44032308 | ||
| Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface | Q44350613 | ||
| beta-Dystroglycan can be revealed in microsomes from mdx mouse muscle by detergent treatment | Q45013684 | ||
| Successful myoblast transplantation in primates depends on appropriate cell delivery and induction of regeneration in the host muscle | Q45855759 | ||
| Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study. | Q45956233 | ||
| Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation. | Q45964692 | ||
| Identification of three distinguishable phenotypes in golden retriever muscular dystrophy. | Q46013069 | ||
| Myoblast transfer in DMD: problems in the interpretation of efficiency | Q46359632 | ||
| Functional resolution of fibrosis in mdx mouse dystrophic heart and skeletal muscle by halofuginone | Q46761904 | ||
| Culture and characterization of human bone marrow mesenchymal stem cells. | Q46846657 | ||
| Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms | Q47248012 | ||
| Direct isolation of satellite cells for skeletal muscle regeneration | Q50756094 | ||
| Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies | Q50892927 | ||
| A dual-marker system for quantitative studies of myoblast transplantation in the mouse. | Q50948447 | ||
| Regeneration and transdifferentiation potential of muscle-derived stem cells propagated as myospheres. | Q51237436 | ||
| The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. | Q52119912 | ||
| Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. | Q52168124 | ||
| Dystrophin expression in the mdx mouse restored by stem cell transplantation. | Q52174025 | ||
| Elevated p21 mRNA level in skeletal muscle of DMD patients and mdx mice indicates either an exhausted satellite cell pool or a higher p21 expression in dystrophin-deficient cells per se. | Q53791002 | ||
| Muscle-derived stem cells isolated as non-adherent population give rise to cardiac, skeletal muscle and neural lineages. | Q54546032 | ||
| Clones of Human Satellite Cells Can Express in Vitro both Fast and Slow Myosin Heavy Chains | Q57268541 | ||
| Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; Report of three expert workshops: TREAT-NMD/ENMC Workshop on outcome measures, 12th–13th May 2007, Naarden, The Netherlands; TREAT-NMD Workshop on outcome measures in exper | Q57588296 | ||
| Myoblast transplantation in non-dystrophic dog | Q58109294 | ||
| The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs | Q59051983 | ||
| An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy | Q59416437 | ||
| Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development | Q61781427 | ||
| Functional regeneration in the hindlimb skeletal muscle of the mdx mouse | Q68002115 | ||
| Rapid death of injected myoblasts in myoblast transfer therapy | Q71890635 | ||
| Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation | Q72139381 | ||
| Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantation | Q73321988 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Duchenne muscular dystrophy | Q1648484 |
| P304 | page(s) | 2501-2518 | |
| P577 | publication date | 2011-09-13 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs | |
| P478 | volume | 179 |
| Q26822437 | Advancements in stem cells treatment of skeletal muscle wasting |
| Q90699692 | Canine Models of Inherited Musculoskeletal and Neurodegenerative Diseases |
| Q37548291 | Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies |
| Q35664379 | Cell therapy in muscular dystrophies: many promises in mice and dogs, few facts in patients |
| Q38954041 | Characterization and Comparison of Canine Multipotent Stromal Cells Derived from Liver and Bone Marrow |
| Q34964840 | Coaxing stem cells for skeletal muscle repair |
| Q27309883 | Differential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell Transplantation |
| Q38029020 | Domestic animal models for biomedical research |
| Q34489678 | Effects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy |
| Q33784964 | Evaluation of bone marrow mononuclear cells as an adjunct therapy to minced muscle graft for the treatment of volumetric muscle loss injuries |
| Q53083043 | First study of intra-arterial delivery of myogenic mononuclear cells to skeletal muscles in primates. |
| Q33555880 | Gait characterization in golden retriever muscular dystrophy dogs using linear discriminant analysis |
| Q97646321 | Human MuStem Cell Grafting into Infarcted Rat Heart Attenuates Adverse Tissue Remodeling and Preserves Cardiac Function |
| Q52714547 | Human serum and platelet lysate are appropriate xeno-free alternatives for clinical-grade production of human MuStem cell batches. |
| Q48223753 | Hydrogel biomaterials and their therapeutic potential for muscle injuries and muscular dystrophies |
| Q36015171 | Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation. |
| Q33887599 | Injectable scaffold materials differ in their cell instructive effects on primary human myoblasts |
| Q38269131 | Invited review: Stem cells and muscle diseases: advances in cell therapy strategies |
| Q40109350 | Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy. |
| Q35653445 | Manipulation of a quasi-natural cell block for high-efficiency transplantation of adherent somatic cells |
| Q36740284 | Microdystrophin ameliorates muscular dystrophy in the canine model of duchenne muscular dystrophy |
| Q37217303 | Neuromuscular disorders: genes, genetic counseling and therapeutic trials |
| Q27013613 | Perspectives of stem cell therapy in Duchenne muscular dystrophy |
| Q34152280 | Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials |
| Q38391853 | Quantitative proteome profiling of dystrophic dog skeletal muscle reveals a stabilized muscular architecture and protection against oxidative stress after systemic delivery of MuStem cells. |
| Q38079633 | Repair or replace? Exploiting novel gene and cell therapy strategies for muscular dystrophies |
| Q46245053 | Skeletal Muscle Regenerative Potential of Human MuStem Cells following Transplantation into Injured Mice Muscle. |
| Q38577279 | Stem Cell Differentiation Toward the Myogenic Lineage for Muscle Tissue Regeneration: A Focus on Muscular Dystrophy |
| Q99568694 | Stem cell therapy for muscular dystrophies |
| Q33902416 | Stem cell transplantation for muscular dystrophy: the challenge of immune response |
| Q92874029 | The Dog Model in the Spotlight: Legacy of a Trustful Cooperation |
| Q33709114 | The golden retriever model of Duchenne muscular dystrophy |
| Q28656377 | The mdx mouse model as a surrogate for Duchenne muscular dystrophy |
| Q59001351 | Translational Research in Stem Cell Treatment of Neuromuscular Diseases |
| Q53097033 | Transplantation of Human Adipose Mesenchymal Stem Cells in Non-Immunosuppressed GRMD Dogs is a Safe Procedure. |
| Q88998647 | Vascular Delivery of Allogeneic MuStem Cells in Dystrophic Dogs Requires Only Short-Term Immunosuppression to Avoid Host Immunity and Generate Clinical/Tissue Benefits |
Search more.